y7 y7 y7 y7 y7 y7
Edition by Elena Bablenis Haveles
y7 y7 y7 y7 y7
CompleteTestBanky7 y7
,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and Prescription Writing
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
Haveles:AppliedPharmacologyfortheDentalHygienist,9thEdition
y7 y7 y7 y7 y7 y7 y7 y7
MULTIPLE CHOICE y7
1. Knowledge of pharmacology aids the dental professional in y7 y7 y7 y7 y7 y7 y7
a. obtaining a patient’s health history. y7 y7 y7 y7
b. administering drugs in the office. y7 y7 y7 y7
c. handling emergency situations. y7 y7
d. selection of a nonprescription medication. y7 y7 y7 y7
e. All of the above. y7 y7 y7
ANS: y 7 E
All of the choices are true. Because many of our patients are being treated with drugs, knowledge of
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
pharmacologyhelps in understanding and interpreting patients’ responses to health history questions.
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
Knowledge of the therapeutic and adverse effects of medications obviously helps in their proper
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
administration in the office. Emergency situations may be caused by drugs or treated by drugs; thus,
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
knowledge of pharmacology is of great help, especially because a rapid response is sometimes required. A
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
clear understanding of the concepts of drug action, drug handling by the body, and drug interactions will
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
allow the dental practitioner to make proper judgments and grasp the concepts relevant to new drug
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
therapies on the market.
y7 y7 y7 y7
DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medication
y 7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienist
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
(Nonprescription Medication) | pp. 2-3
y7 OBJ: 1 y7 y7 y7 y7
TOP: NBDHE, 6.0. Pharmacology y 7 y7 y7
2. Which of the following statements is true regarding planning appointments?
y7 y7 y7 y7 y7 y7 y7 y7 y7
a. Whether or not patients are taking medication for systemic diseases is of little y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
consequence in the dental office. y7 y7 y7 y7
b. Asthmatic patients should have dental appointments in the morning. y7 y7 y7 y7 y7 y7 y7 y7
c. Diabetic patients usuallyhave fewer problems with a morning appointment y7 y7 y7 y7 y7 y7 y7 y7 y7
compared with afternoon appointments.
y7 y7 y7 y7
d. Both B and C are true. y7 y7 y7 y7 y7
ANS: y 7 D
Asthmatic patients who experience dental anxiety should schedule their appointments when they are not
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer problems
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
with a morning appointment. Patients taking medication for systemic diseases may require special handling
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
in the dental office.
y7 y7 y7 y7
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) |p. 3
y 7 y7 y7 y7 y7 y7 y7 y7 y7 y7
OBJ: 1
y7 TOP: NBDHE, 6.0. Pharmacology
y 7 y 7 y7 y7
,3. Nutritional or herbal supplements y7 y7 y7
a. carrythe U.S. Food and Drug Administration (FDA) approval for disease states. y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
b. are not drugs. y7 y7
c. can cause adverse effects. y7 y7 y7
d. will not interact with other drugs the patient may be taking. y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
ANS: y 7 C
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of nutritional or y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
herbal supplements do not carry FDA approval for treating disease states. These supplements are drugs and
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
can cause adverse effects and interact with different drugs.
y7 y7 y7 y7 y7 y7 y7 y7 y7
DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) |p. 3
y 7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
OBJ: 1
y7 TOP: NBDHE, 6.0. Pharmacology
y 7 y 7 y7 y7
4. Which type of drug name usually begins with a lowercase letter?
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
a. Brand name y7
b. Code name y7
c. Genericname y7
d. Trade name y7
ANS: y 7 C
Before anydrug is marketed, it is given a generic name that becomes the “official” name of the drug. Each
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
drug is assigned only one generic name selected by the U.S. Adopted Name Council, and the name is not
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
capitalized. The brand name is equivalent to the trade name and is capitalized. Although the brand name is
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
technicallythe name of the companymarketing the product, this term is often used interchangeably with the
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
trade name. The code name is the initial term used within a pharmaceutical company to refer to a drug while
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
it is undergoing investigation and is often a combination of capital letters and numbers, the letters
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
representing an abbreviation of the company name.
y7 y7 y7 y7 y7 y7 y7
DIF: Comprehension REF: DrugNames |p. 4 y 7 y7 y7 y7 y7
OBJ: 3
y7 TOP: y 7 y 7 NBDHE, 6.0. Pharmacology y7 y7
5. A drug’s generic name is selected by the
y7 y7 y7 y7 y7 y7 y7
a. pharmaceutical company manufacturing it. y7 y7 y7
b. Food and Drug Administration (FDA). y7 y7 y7 y7
c. U.S. Adopted Name Council. y7 y7 y7
d. Federal Patent Office. y7 y7
ANS: y 7 C
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted Name
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
Council. The generic name is not selected by the FDA or the Federal Patent Office. The pharmaceutical
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
company manufacturing the drug clearlyhas an influence on the generic name given its drug, but the final
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
decision is not the company’s.
y7 y7 y7 y7 y7
DIF: Recall REF: Drug Names | p. 4 y 7 y7 y7 y7 y7 OBJ:
y3 TOP: NBDHE, 6.0. Pharmacology
7 y7 y 7 y7 y7
6. Which of the following is true concerning generic and trade names of drugs?
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
a. A drug may only have one generic name and one trade name.
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
, b. A drug may only have one generic name, but it may have several trade names.
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
c. A drug may have several generic names, but it may only have one trade name.
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
d. A drug may have several generic names and several trade names.
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
ANS: y 7 B
Each drug has only one generic name but may have several trade names. For each drug, there is only one
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
generic name. It is not capitalized, and it becomes the “official” name of the drug. The pharmaceutical
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
company discovering the drug gives the drug a trade name. The trade name is protected by the Federal
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
Patent Law for 20 years from the earliest claimed filing date, plus patent term extensions. Although the
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
brand name is technically the name of the companymarketing the product, it is often used interchangeably
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
with the trade name.
y7 y7 y7 y7
DIF: Comprehension REF: DrugNames |p. 4 y 7 y7 y7 y7 y7
OBJ: 3
y7 TOP: y 7 y 7 NBDHE, 6.0. Pharmacology y7 y7
7. Two drugs that are found to be chemicallyequivalent, but not biologically equivalent or
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
y7 therapeutically equivalent are said to differ in y7 y7 y7 y7 y7 y7
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. y7
ANS: y 7 C
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. These
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
products are said to differ in their bioavailability. The potencyof a drug is a function of the amount of drug
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
required to produce an effect. The efficacy is the maximum intensity of effect or response that can be
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
produced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of the experimental animals
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
divided by the effective dose for 50% of the experimental animals. If the value of the therapeutic index is
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
small, toxicity is more likely.
y7 y7 y7 y7 y7
DIF: Recall REF: y 7 DrugNames (Drug Substitution) |p. 5 y7 y7 y7 y7 y7 y7
OBJ: 4
y7 y 7 TOP: y 7 NBDHE, 6.0. Pharmacology y7 y7
8. How many years must pass after a drug patent expires before other drug companies can market the same
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
compound as a generic drug?
y7 y7 y7 y7 y7
a. 20 years y7
b. 17 years y7
c. 7 years y7
d. 0 years y7
ANS: y 7 D
Once a drug patent expires, competing companies may immediately market the same compound in generic
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
form. The pharmaceutical company discovering the drug gives the drug a trade name. The trade name is
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
protected by the Federal Patent Law for 20 years from the earliest claimed filing date, plus the patent term
y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7 y7
extensions.
y7
DIF: Application REF: y 7 DrugNames (Drug Substitution) |p. 5 y7 y7 y7 y7 y7 y7
OBJ: 4
y7 y 7 TOP: y 7 NBDHE, 6.0. Pharmacology y7 y7